Comparing the Outcomes of Pediatric Liver Transplantation.

Autor: Polat KY; Organ Transplantation Center, Bahçelievler Memorial Hospital, Istanbul, Turkey., Yazar Ş; Organ Transplantation Center, Bahçelievler Memorial Hospital, Istanbul, Turkey., Aslan S; Organ Transplantation Center, Bahçelievler Memorial Hospital, Istanbul, Turkey., Kargı A; Organ Transplantation Center, Bahçelievler Memorial Hospital, Istanbul, Turkey., Selimoğlu A; Department of Pediatric Gastroenterology, Bahçelievler Memorial Hospital, Istanbul, Turkey., Gürbulak B; Organ Transplantation Center, Bahçelievler Memorial Hospital, Istanbul, Turkey. Electronic address: bgurbulak@gmail.com., Astarcıoğlu İ; Organ Transplantation Center, Bahçelievler Memorial Hospital, Istanbul, Turkey.
Jazyk: angličtina
Zdroj: Transplantation proceedings [Transplant Proc] 2023 Jun; Vol. 55 (5), pp. 1214-1222. Date of Electronic Publication: 2023 Jun 09.
DOI: 10.1016/j.transproceed.2023.05.004
Abstrakt: Background: Liver transplantation is a life-saving treatment for end-stage pediatric liver failure. We aimed to present the results of pediatric liver transplants performed in our center in the last 11 years (between 2012 and March 2022) in association with prognostic factors affecting survival.
Methods: Demographic characteristics, etiologic reasons, previous operations (Kasai procedure), morbidity, mortality, survival, and bilio-vascular complication rates were determined, and outcomes were evaluated. In the postoperative period, the duration of mechanical ventilation and intensive care unit stay and surgical and other complications were evaluated. Graft and patient survival rates were determined, and univariate and multivariate factors affecting these rates were evaluated.
Results: In the last 10 years, 229 pediatric liver transplantaion (Pe-LT)/1513 adult liver taransplantation (Ad-LT) (21.35%) were performed in our center. This ratio (Pe-LT/Ad-LT ratio) is 1741/15,886 (10.95%) for our country. A total of 229 liver transplants were performed in 214 pediatric patients. Retransplantation was performed in 15 patients (6.55%). Cadaveric liver transplantation was performed in 9 patients. Graft survival rates were 87%, 83%, 78%, 78%, 78%, and 78% at <30 days, 30 to 90 days, 91 to 364 days, 1 to 3 years, and >3 years, respectively. Patient survival rates for <30 days, 30 to 90 days, 91 to 364 days, 1 to 3 years, and >3 years were 91.5%, 85.7%, 82%, 81.5%, and 81.5%, respectively. Our 5-year survival rates in metabolic diseases and the acute fulminant failure group are 93.8% and 100%, respectively.
Conclusions: The fact that the 1- and 5-year survival rates are the same shows that when patients overcome biliary vascular and infectious problems, their survival is prolonged.
Competing Interests: Declaration of Competing Interest All the authors declare no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper”.
(Copyright © 2023 Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: